IL1B and COVID-19: Due to the common pathway of IL-1 that shares the pathophysiology of pustular psoriasis as well as the inflammatory process and/or the unstable cytokine production triggered by COVID-19 vaccination [11,12], anakinra was initiated with a daily subcutaneous injection of 100 mg.